METHOD FOR RADIONUCLIDE DIAGNOSING OF CEREBRAL TUMORS Russian patent published in 2019 - IPC A61B6/00 A61K49/00 A61K49/04 A61K103/10 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to oncologists, and can be used for radionuclide diagnostics of anaplastic astrocytoma. Patient is administered a radiopharmaceutical preparation based on technetium-99m labeled glucose derivative containing 1-thio-D-glucose sodium hydrate salt 0.625 mg, tin dichloride 2-water 0.044–0.052 mg, ascorbic acid not more than 0.125 mg, sodium chloride 8.0–10.0 mg, water for injections up to 1 ml, 500 MBq. 40 minutes after the intravenous introduction of the preparation, one-photon emission computed tomography is performed on a two-detector gamma camera. Obtained images are subjected to post-processing processing. When visualizing asymmetric areas of hyperfixation of the preparation in the projection of the brain, a malignant growth is diagnosed.

EFFECT: method provides the diagnostic accuracy and informativity by administering a radiopharmaceutical based on the technetium-99m labeled glucose derivative.

1 cl, 2 dwg, 1 tbl, 1 ex